Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings

INTRODUCTION: Infant HIV prophylaxis with broadly neutralizing anti‐HIV antibodies (bNAbs) could provide long‐acting protection against vertical transmission. We sought to estimate the potential clinical impact and cost‐effectiveness of hypothetical bNAb prophylaxis programmes for children known to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dugdale, Caitlin M., Ufio, Ogochukwu, Alba, Christopher, Permar, Sallie R., Stranix‐Chibanda, Lynda, Cunningham, Coleen K., Fouda, Genevieve G., Myer, Landon, Weinstein, Milton C., Leroy, Valériane, McFarland, Elizabeth J., Freedberg, Kenneth A., Ciaranello, Andrea L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816086/
https://www.ncbi.nlm.nih.gov/pubmed/36604316
http://dx.doi.org/10.1002/jia2.26052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816086/
https://www.ncbi.nlm.nih.gov/pubmed/36604316
http://dx.doi.org/10.1002/jia2.26052

Ejemplares similares